RxDoctor Payments Data

Adam Bihl, MD

Family Medicine · Ontario, OHNPI 1164465480

Payments from drug & device makers

$833in general payments, 2019–2025

Across 59 payments — averaging $14.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$284
  • Novo Nordisk$99
  • Lilly USA, LLC$90
  • Amgen$64
  • Phathom Pharmaceuticals, Inc.$56
  • Johnson & Johnson$54
  • plus $187 from 9 others

What the payments were for

  • Food & beverage$833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$833 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$135,317
Medicare patients
530
Services billed
1,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide108$118,757
EliquisApixaban93$103,566
OzempicSemaglutide42$57,026
TrulicityDulaglutide43$44,266
JanuviaSitagliptin Phosphate35$41,660
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$30,782
JanumetSitagliptin Phos/Metformin Hcl24$30,197
OtezlaApremilast12$28,662
LinzessLinaclotide32$24,763
XareltoRivaroxaban21$24,615
FarxigaDapagliflozin Propanediol22$22,641
Celecoxib215$13,127
Repatha SureclickEvolocumab11$11,304
TrintellixVortioxetine Hydrobromide11$9,641
SymbicortBudesonide/Formoterol Fumarate13$8,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$90$163,023151 claims
PfizerEliquis, Prempro$14$107,573104 claims
MerckJanuvia, Janumet$17$71,85759 claims
Novo NordiskOzempic$99$57,02642 claims
GSKTrelegy Ellipta$31$30,78240 claims
AstraZenecaFarxiga, Symbicort$49$30,66835 claims
AbbVieLinzess, Synthroid$284$29,052122 claims
AmgenOtezla$64$28,66212 claims
Johnson & JohnsonXarelto$54$24,61521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Ontario

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →